OTTAWA, ON, Oct. 22, 2021 /CNW/ - Charcuterie L. Fortin Ltée. is recalling Charcuterie Fortin brand Salami from the marketplace because it may contain wheat which is not declared on the label. People who have an allergy to wheat or have celiac disease or other gluten-related disorders should not consume the recalled product described below.
The following product has been sold in Quebec.
Recalled product
Brand
Product
Size
UPC
Codes
Charcuterie Fortin
Salami
175 g
6 28555 04100 4
Best Before 2021NO13
22732
What you should do
Check to see if you have the recalled product in your home. Recalled products should be thrown out or returned to the store where they were purchased.
If you have an allergy to wheat or have celiac disease or other gluten-related disorders, do not consume the recalled product as it may cause a serious or life-threatening reaction.
This recall was triggered by the company. The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.
The CFIA is verifying that industry is removing the recalled product from the marketplace.
Reactions
There have been no reported reactions associated with the consumption of this product.
Innovations in patient care developed at Florida Cancer Specialists & Research Institute, LLC (FCS) will be presented at the Oncology Nursing Society 49th Annual Congress in Washington, DC, the largest global gathering dedicated to oncology nursing....
FORUS Therapeutics Inc. ("FORUS") is deeply disappointed and disagrees with the recent decision by the Honourable Christian Dubé, Minister of Health and Social Services in Quebec to deny listing XPOVIO® (selinexor) in combination with VELCADE®...
The Inception Company, trusted provider of meeting solutions to the life sciences industry and HCPs (healthcare professionals) for over 20 years and known for its Pandotm platform, announces a pivotal role expansion for its in-house Executive...
n-Lorem, a nonprofit foundation, announced a new partnership with Hongene Biotech Corporation that supports n-Lorem's efforts to discover and provide personalized experimental antisense oligonucleotide (ASO) medicines to nano-rare disease patients (1...
Synaptogenix, Inc. ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced that it received notice from The Nasdaq Stock Market LLC ("Nasdaq") on April 22,...
For over 30 years Protocall's behavioral health contact center, HelpNow, has set industry standards for round-the-clock access to high-quality crisis care. Received calls are documented within Protocall's custom database and sent to the caller's care...